Clinical trial
Efficacy of the Nanodropper Device on Intraocular Pressure in Patients With Glaucoma
NCT05273385 is registered in ClinicalTrials.gov with University of California, San Francisco as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Efficacy of the Nanodropper Device on Intraocular Pressure in Patients With Glaucoma
- Lead sponsor
- University of California, San Francisco
- Phase
- Not applicable
- Overall status
- Terminated
- Start date
- October 10, 2022
- Completion date
- December 10, 2024
- Enrollment
- 16 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
glaucoma, ocular hypertension, open angle glaucoma